Matches in SemOpenAlex for { <https://semopenalex.org/work/W2759207813> ?p ?o ?g. }
- W2759207813 abstract "Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by severe hypophosphatemia and osteomalacia. Nonspecific symptoms make the diagnosis elusive. In addition, locating the responsible tumor(s) is challenging. The aim of this study was to investigate the clinical management and outcomes of TIO. The clinical features, diagnostic procedures, treatment, and outcomes of 12 patients were reviewed retrospectively. The cohort comprised six men and six women (mean age 45.5 ± 9.9 years, range 23–61 years). The mean duration of disease was 3.7 ± 2.6 years. All patients manifested progressive bone pain, muscle weakness, and/or difficulty walking. Serum phosphorus concentrations were low in all patients (mean 0.42 ± 0.12 mmol/L). Technetium-99m octreotide scintigraphy was performed in 11 patients and showed lesions in the right distal femur, left femoral head, and right tibial plateau, respectively, in three patients. Magnetic resonance imaging (MRI) was negative for lesions in one patient. Two patients underwent biopsies that showed negative histopathology. Two patients, at 2 years and 8 months, respectively, after having negative technetium-99m octreotide studies, underwent 18F–fluorodeoxyglucose positron emission tomography/computed tomography (CT), which revealed lesions in the sacrum and soft tissue of the left palm, respectively. One tumor was detected by CT and MRI. Overall, lesion sites were the head (two patients, 16.7%), thoracic and lumbar region (two, 16.7%), pelvis (three, 25%), lower limbs (four, 33.3%), and upper limbs (one, 8.3%). All patients underwent surgery, and histopathology showed phosphaturic mesenchymal tumors in each. Postoperatively, serum phosphorus concentrations normalized within 2–7 days in 11 patients. With follow-ups of 1–41 months, surgery was effective in 10 patients. One patient developed local recurrence and another had metastases. Locating tumors responsible for tumor-induced osteomalacia is often challenging. Although complete tumor resection confers a good prognosis in most patients, surveillance for recurrence and metastasis is necessary. Before surgery or when surgery is not indicated, oral phosphate can alleviate symptoms and metabolic imbalance." @default.
- W2759207813 created "2017-10-06" @default.
- W2759207813 creator A5000432967 @default.
- W2759207813 creator A5033020983 @default.
- W2759207813 creator A5042105305 @default.
- W2759207813 creator A5059407571 @default.
- W2759207813 creator A5059810429 @default.
- W2759207813 creator A5061130250 @default.
- W2759207813 creator A5068175335 @default.
- W2759207813 creator A5078004749 @default.
- W2759207813 creator A5078149457 @default.
- W2759207813 creator A5081872382 @default.
- W2759207813 date "2017-09-21" @default.
- W2759207813 modified "2023-10-16" @default.
- W2759207813 title "Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients" @default.
- W2759207813 cites W1840240872 @default.
- W2759207813 cites W1965642438 @default.
- W2759207813 cites W1969147075 @default.
- W2759207813 cites W2000347238 @default.
- W2759207813 cites W2004940062 @default.
- W2759207813 cites W2020598094 @default.
- W2759207813 cites W2048989525 @default.
- W2759207813 cites W2049625022 @default.
- W2759207813 cites W2057823163 @default.
- W2759207813 cites W2058085210 @default.
- W2759207813 cites W2066270273 @default.
- W2759207813 cites W2068788086 @default.
- W2759207813 cites W2083116747 @default.
- W2759207813 cites W2105952078 @default.
- W2759207813 cites W2121631968 @default.
- W2759207813 cites W2136483324 @default.
- W2759207813 cites W2228440519 @default.
- W2759207813 cites W2234371586 @default.
- W2759207813 cites W2340289042 @default.
- W2759207813 cites W2404289018 @default.
- W2759207813 cites W2410649196 @default.
- W2759207813 cites W2585604649 @default.
- W2759207813 cites W2791436097 @default.
- W2759207813 doi "https://doi.org/10.1186/s12891-017-1756-1" @default.
- W2759207813 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5609032" @default.
- W2759207813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28934935" @default.
- W2759207813 hasPublicationYear "2017" @default.
- W2759207813 type Work @default.
- W2759207813 sameAs 2759207813 @default.
- W2759207813 citedByCount "42" @default.
- W2759207813 countsByYear W27592078132018 @default.
- W2759207813 countsByYear W27592078132019 @default.
- W2759207813 countsByYear W27592078132020 @default.
- W2759207813 countsByYear W27592078132021 @default.
- W2759207813 countsByYear W27592078132022 @default.
- W2759207813 countsByYear W27592078132023 @default.
- W2759207813 crossrefType "journal-article" @default.
- W2759207813 hasAuthorship W2759207813A5000432967 @default.
- W2759207813 hasAuthorship W2759207813A5033020983 @default.
- W2759207813 hasAuthorship W2759207813A5042105305 @default.
- W2759207813 hasAuthorship W2759207813A5059407571 @default.
- W2759207813 hasAuthorship W2759207813A5059810429 @default.
- W2759207813 hasAuthorship W2759207813A5061130250 @default.
- W2759207813 hasAuthorship W2759207813A5068175335 @default.
- W2759207813 hasAuthorship W2759207813A5078004749 @default.
- W2759207813 hasAuthorship W2759207813A5078149457 @default.
- W2759207813 hasAuthorship W2759207813A5081872382 @default.
- W2759207813 hasBestOaLocation W27592078131 @default.
- W2759207813 hasConcept C126322002 @default.
- W2759207813 hasConcept C126838900 @default.
- W2759207813 hasConcept C141071460 @default.
- W2759207813 hasConcept C142724271 @default.
- W2759207813 hasConcept C143409427 @default.
- W2759207813 hasConcept C167135981 @default.
- W2759207813 hasConcept C2776049877 @default.
- W2759207813 hasConcept C2776541429 @default.
- W2759207813 hasConcept C2778049618 @default.
- W2759207813 hasConcept C2778573388 @default.
- W2759207813 hasConcept C544855455 @default.
- W2759207813 hasConcept C71924100 @default.
- W2759207813 hasConceptScore W2759207813C126322002 @default.
- W2759207813 hasConceptScore W2759207813C126838900 @default.
- W2759207813 hasConceptScore W2759207813C141071460 @default.
- W2759207813 hasConceptScore W2759207813C142724271 @default.
- W2759207813 hasConceptScore W2759207813C143409427 @default.
- W2759207813 hasConceptScore W2759207813C167135981 @default.
- W2759207813 hasConceptScore W2759207813C2776049877 @default.
- W2759207813 hasConceptScore W2759207813C2776541429 @default.
- W2759207813 hasConceptScore W2759207813C2778049618 @default.
- W2759207813 hasConceptScore W2759207813C2778573388 @default.
- W2759207813 hasConceptScore W2759207813C544855455 @default.
- W2759207813 hasConceptScore W2759207813C71924100 @default.
- W2759207813 hasIssue "1" @default.
- W2759207813 hasLocation W27592078131 @default.
- W2759207813 hasLocation W27592078132 @default.
- W2759207813 hasLocation W27592078133 @default.
- W2759207813 hasLocation W27592078134 @default.
- W2759207813 hasLocation W27592078135 @default.
- W2759207813 hasOpenAccess W2759207813 @default.
- W2759207813 hasPrimaryLocation W27592078131 @default.
- W2759207813 hasRelatedWork W1989969368 @default.
- W2759207813 hasRelatedWork W2023315657 @default.
- W2759207813 hasRelatedWork W2074647007 @default.
- W2759207813 hasRelatedWork W2132060372 @default.
- W2759207813 hasRelatedWork W2171789403 @default.